首页> 外文期刊>Journal of drug targeting >Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics
【24h】

Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics

机译:乳腺癌和卵巢癌作用的纳米颗粒系统的研制:纳米托

获取原文
获取原文并翻译 | 示例
           

摘要

The use of nanoparticulate systems with action in breast and ovarian cancer has been highlighted in recent years as an alternative to increasing the therapeutic index of conventional anticancer drugs. Thus, nanoparticles have advantageous characteristics in the treatment of cancer. Several nanocarriers of drugs and nanoparticles are described in the literature. The pharmacokinetics of the drugs can be modified by the use of nanocarriers, which in turn facilitate the specific delivery of the drug to the tumour cell. Therefore, the present work is a review that examines some nanosystems with nanoparticles for action in the treatment of breast cancer and ovarian cancer.
机译:近年来突出了在乳腺癌和卵巢癌中具有作用的纳米颗粒系统作为增加常规抗癌药物治疗指数的替代方案。 因此,纳米颗粒在治疗癌症时具有有利的特征。 文献中描述了一些药物和纳米颗粒的纳米载体。 药物的药代动力学可以通过使用纳米载体来修饰,这又促进药物的特定递送到肿瘤细胞。 因此,本作综述是一种审查,该方法将一些纳米系统用纳米颗粒用于治疗乳腺癌和卵巢癌的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号